Published in Hypertension on September 19, 2011
Association of age and BMI with kidney function and mortality: a cohort study. Lancet Diabetes Endocrinol (2015) 2.29
Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circ Res (2015) 1.45
Obesity-associated hypertension: recent progress in deciphering the pathogenesis. Hypertension (2014) 1.06
Links between ectopic fat and vascular disease in humans. Arterioscler Thromb Vasc Biol (2014) 1.02
Intramuscular fat and associations with metabolic risk factors in the Framingham Heart Study. Arterioscler Thromb Vasc Biol (2013) 1.02
Chronic kidney disease defined by cystatin C predicts mobility disability and changes in gait speed: the Framingham Offspring Study. J Gerontol A Biol Sci Med Sci (2013) 0.93
Waist circumference, not body mass index, is associated with renal function decline in korean population: hallym aging study. PLoS One (2013) 0.88
Multiple adipose depots increase cardiovascular risk via local and systemic effects. Curr Atheroscler Rep (2013) 0.87
Lifestyle factors and indices of kidney function in the Framingham Heart Study. Am J Nephrol (2015) 0.84
Beyond Body Mass Index: Advantages of Abdominal Measurements for Recognizing Cardiometabolic Disorders. Am J Med (2015) 0.84
Ectopic Adipose Tissue Storage in the Left and the Right Renal Sinus is Asymmetric and Associated With Serum Kidney Injury Molecule-1 and Fibroblast Growth Factor-21 Levels Increase. EBioMedicine (2016) 0.82
Impact of Mediterranean diet on metabolic syndrome, cancer and longevity. Oncotarget (2016) 0.81
Relationship between changes in body fat and a decline of renal function in the elderly. PLoS One (2014) 0.80
Short-term changes after a weight reduction intervention in advanced diabetic nephropathy. Clin J Am Soc Nephrol (2013) 0.79
Short-Term High Fat Intake Does Not Significantly Alter Markers of Renal Function or Inflammation in Young Male Sprague-Dawley Rats. J Nutr Metab (2015) 0.79
Heritability and genome-wide association analysis of renal sinus fat accumulation in the Framingham Heart Study. BMC Med Genet (2011) 0.79
Fat chance for hypertension and chronic kidney disease. Hypertension (2011) 0.79
Post-weaning high-fat diet accelerates kidney injury, but not hypertension programmed by maternal diabetes. Pediatr Res (2015) 0.78
Regional Fat Distribution and Blood Pressure Level and Variability: The Dallas Heart Study. Hypertension (2016) 0.78
Para- and perirenal ultrasonographic fat thickness is associated with 24-hours mean diastolic blood pressure levels in overweight and obese subjects. BMC Cardiovasc Disord (2015) 0.77
Measurement of visceral fat: should we include retroperitoneal fat? PLoS One (2014) 0.77
Role of the Renal Microcirculation in Progression of Chronic Kidney Injury in Obesity. Am J Nephrol (2016) 0.76
The impact of insulin resistance on the kidney and vasculature. Nat Rev Nephrol (2016) 0.75
Perirenal fat thickness measured with computed tomography is a reliable estimate of perirenal fat mass. PLoS One (2017) 0.75
Left ventricular mass: correlation with fatness, hemodynamics and renal morphology. Pol J Radiol (2014) 0.75
Role of Renal Sinus Adipose Tissue in Obesity-induced Renal Injury. EBioMedicine (2016) 0.75
Body-mass index and risk of advanced chronic kidney disease: Prospective analyses from a primary care cohort of 1.4 million adults in England. PLoS One (2017) 0.75
High-fat diet amplifies renal renin angiotensin system expression, blood pressure elevation, and renal dysfunction caused by Ceacam1 null deletion. Am J Physiol Endocrinol Metab (2015) 0.75
Rationale, design, and methods for Canadian alliance for healthy hearts and minds cohort study (CAHHM) - a Pan Canadian cohort study. BMC Public Health (2016) 0.75
Data set for renal sinus fat volume and visceral adipose tissue volume on computed tomography. Data Brief (2016) 0.75
Obesity and renovascular disease. Am J Physiol Renal Physiol (2015) 0.75
Obesity and kidney disease: Hidden consequences of the epidemic. Indian J Nephrol (2017) 0.75
Obesity and kidney disease: hidden consequences of the epidemic. Clin Kidney J (2017) 0.75
The association between renal sinus fat area and the progression-free survival in Chinese non-metastatic clear-cell renal cell carcinoma patients. Oncotarget (2017) 0.75
Upper Body Subcutaneous Fat Is Associated with Cardiometabolic Risk Factors. Am J Med (2017) 0.75
Obesity and Kidney Disease: Hidden Consequences of the Epidemic. Kidney Dis (Basel) (2017) 0.75
Obesity and kidney disease: hidden consequences of the epidemic. Pediatr Nephrol (2017) 0.75
Prevalence and trends in obesity among US adults, 1999-2008. JAMA (2010) 50.58
Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med (2006) 32.81
Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis (2008) 15.04
Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation (2007) 12.79
Genome-wide association study of blood pressure and hypertension. Nat Genet (2009) 11.54
Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond) (2008) 9.45
Predictors of new-onset kidney disease in a community-based population. JAMA (2004) 7.45
Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis (2002) 7.03
Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int (2004) 6.32
Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol (2009) 6.23
Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation (2008) 5.95
Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int (2008) 5.90
Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol (2005) 3.96
Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study. Hepatology (2010) 3.60
Neck circumference as a novel measure of cardiometabolic risk: the Framingham Heart study. J Clin Endocrinol Metab (2010) 3.39
The medical complications of obesity. QJM (2006) 2.93
Measurement of renal function in chronic renal disease. Kidney Int (1990) 2.72
Cystatin C as a risk factor for outcomes in chronic kidney disease. Ann Intern Med (2007) 2.71
Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis (2005) 2.30
Ectopic fat storage in heart, blood vessels and kidneys in the pathogenesis of cardiovascular diseases. Int J Obes Relat Metab Disord (2004) 2.15
Renal sinus fat and poor blood pressure control in middle-aged and elderly individuals at risk for cardiovascular events. Hypertension (2010) 1.93
Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study. Am J Kidney Dis (2008) 1.82
Structural and functional changes in the kidneys of high-fat diet-induced obese mice. Am J Physiol Renal Physiol (2008) 1.47
Cathepsin s promotes human preadipocyte differentiation: possible involvement of fibronectin degradation. Endocrinology (2006) 1.45
Obesity-induced hypertension. Renal function and systemic hemodynamics. Hypertension (1993) 1.43
Renal interstitial pressure and sodium excretion during renal vein constriction. Am J Physiol (1980) 1.31
Effect of renal lipid accumulation on proximal tubule Na+/H+ exchange and ammonium secretion. Am J Physiol Renal Physiol (2008) 1.27
Novel measurements of periaortic adipose tissue in comparison to anthropometric measures of obesity, and abdominal adipose tissue. Int J Obes (Lond) (2009) 1.23
Impact of obesity on renal structure and function in the presence and absence of hypertension: evidence from melanocortin-4 receptor-deficient mice. Am J Physiol Regul Integr Comp Physiol (2009) 1.13
Differential estimation of CKD using creatinine- versus cystatin C-based estimating equations by category of body mass index. Am J Kidney Dis (2009) 1.10
Pressures in static and dynamic states from capsules implanted in the kidney. Am J Physiol (1971) 1.07
Obesity and hypertension: mechanisms, cardio-renal consequences, and therapeutic approaches. Med Clin North Am (2009) 1.07
Renal sinus lipomatosis and body composition in hypertensive, obese rabbits. Int J Obes Relat Metab Disord (1995) 1.02
Nuclear magnetic resonance imaging of the kidney. Radiology (1983) 1.00
Association of visceral and subcutaneous adiposity with kidney function. Clin J Am Soc Nephrol (2008) 1.00
Segmental analysis of sodium reabsorption during renal vein constriction. Am J Physiol (1982) 0.97
Metabolic syndrome, C-reactive protein, and chronic kidney disease in nondiabetic, nonhypertensive adults. Am J Hypertens (2007) 0.96
Intraglomerular lipid deposition in routine biopsies. Clin Nephrol (1991) 0.90
Abnormal kidney function as a cause and a consequence of obesity hypertension. Clin Exp Pharmacol Physiol (1998) 0.85
Obesity-induced hypertension in the dog. Hypertension (1987) 0.84
Kidneys in infants and children: evaluation with MR. Radiology (1986) 0.81
Effects of renal lymphatic occlusion and venous constriction on renal function. Am J Pathol (1975) 0.79
Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98
Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79
Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07
Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02
General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation (2008) 26.42
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08
Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature (2010) 20.01
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89
Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet (2010) 16.96
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25
Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation (2007) 12.79
Metabolite profiles and the risk of developing diabetes. Nat Med (2011) 12.22
Genome-wide association study of blood pressure and hypertension. Nat Genet (2009) 11.54
Variants in MTNR1B influence fasting glucose levels. Nat Genet (2008) 10.85
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med (2014) 10.54
The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination. Am J Epidemiol (2007) 9.90
Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med (2008) 9.68
Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation (2010) 9.09
Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med (2013) 8.91
Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation (2004) 8.80
Outcomes of anatomical versus functional testing for coronary artery disease. N Engl J Med (2015) 8.70
Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Arch Intern Med (2007) 8.59
A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell (2004) 8.18
Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet (2010) 7.94
Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol (2003) 7.47
Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet (2009) 7.27
Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet (2010) 6.66
Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2014) 6.55
Presentation of multivariate data for clinical use: The Framingham Study risk score functions. Stat Med (2004) 6.42
Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community. Circulation (2007) 6.34
Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med (2007) 6.29
Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2012) 6.24
Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2013) 6.13
Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation (2008) 5.95
Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet (2008) 5.89
Percutaneous repair or surgery for mitral regurgitation. N Engl J Med (2011) 5.78
Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med (2007) 5.77
New loci associated with kidney function and chronic kidney disease. Nat Genet (2010) 5.58
Loss-of-function mutations in APOC3, triglycerides, and coronary disease. N Engl J Med (2014) 5.47
Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab (2006) 5.33
Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation (2007) 5.10
The Framingham Heart Study 100K SNP genome-wide association study resource: overview of 17 phenotype working group reports. BMC Med Genet (2007) 5.02
Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation (2009) 4.87
Association of smoking cessation and weight change with cardiovascular disease among adults with and without diabetes. JAMA (2013) 4.81
Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet (2009) 4.78
A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. JAMA (2003) 4.77
Long-term results of carotid stenting versus endarterectomy in high-risk patients. N Engl J Med (2008) 4.72
Predicting the 30-year risk of cardiovascular disease: the framingham heart study. Circulation (2009) 4.62
A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet (2012) 4.37
Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium. Nat Genet (2009) 4.28
Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation (2005) 4.08
Non-inferiority trials: design concepts and issues - the encounters of academic consultants in statistics. Stat Med (2003) 4.07
Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways. Diabetes (2010) 4.07
Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet (2011) 3.92
Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study. Hepatology (2010) 3.60
The CT-STAT (Coronary Computed Tomographic Angiography for Systematic Triage of Acute Chest Pain Patients to Treatment) trial. J Am Coll Cardiol (2011) 3.58
Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study. Eur Heart J (2009) 3.54
Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol (2006) 3.48
Arterial inflammation in patients with HIV. JAMA (2012) 3.42
Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure. Nat Genet (2011) 3.40
Neck circumference as a novel measure of cardiometabolic risk: the Framingham Heart study. J Clin Endocrinol Metab (2010) 3.39
Effect of aging on A1C levels in individuals without diabetes: evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001-2004. Diabetes Care (2008) 3.33
On the replication of genetic associations: timing can be everything! Am J Hum Genet (2008) 3.32
Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat Genet (2013) 3.25
Genetic variants at 2q24 are associated with susceptibility to type 2 diabetes. Hum Mol Genet (2010) 3.24
Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J Clin Invest (2011) 3.23
Diagnostic and prognostic value of absence of coronary artery calcification. JACC Cardiovasc Imaging (2009) 3.23
Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005. Circulation (2009) 3.23
Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet (2012) 3.21
Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma. Nat Genet (2011) 3.18
NRXN3 is a novel locus for waist circumference: a genome-wide association study from the CHARGE Consortium. PLoS Genet (2009) 3.18
Genetic variation in white matter hyperintensity volume in the Framingham Study. Stroke (2004) 3.13
Detection of calcified and noncalcified coronary atherosclerotic plaque by contrast-enhanced, submillimeter multidetector spiral computed tomography: a segment-based comparison with intravascular ultrasound. Circulation (2003) 3.09
Visceral fat is associated with lower brain volume in healthy middle-aged adults. Ann Neurol (2010) 3.05
Framingham Heart Study 100K Project: genome-wide associations for blood pressure and arterial stiffness. BMC Med Genet (2007) 3.04